Definitive Contract W911QY12C0028

<p>This is a $493,000.00 firm fixed price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Catalent Maryland, Inc. (doing business as Paragon Biosciences). The contract does not have a set-aside designation. The contract supports work related to NIDA's programs, with an ultimate completion date of September 27, 2017. Catalent Maryland, Inc. is the prime contractor for this award.</p>

This is a $7,935,685.07 Cost Plus Fixed Fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response, which is part of the U.S. Department of Health and Human Services, to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The contract is for testing and shelf-life extension of a U.S. Government-owned adjuvant for pandemic preparedness, under the Centers for Innovation in Advanced Development and...

This is a $1,628,690,592.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Bavarian Nordic A/S, a for-profit biotechnology company based in Denmark. The contract has a firm fixed price pricing type and an ultimate completion date of September 26, 2027. It is not a set-aside contract. Bavarian Nordic A/S is providing the government with various goods and services, including endpoint titer analysis services involving...

This is a delivery order awarded to Biofire Defense LLC, a for-profit limited liability company, by the Joint PEO Chemical and Biological Defense organization of the U.S. Department of Defense. The $9,332,416.09 cost-plus-fixed-fee contract is for the provision of &quot;BWA OPTIMIZED CLINICAL/ENVIRONMENTAL&quot; products and services. This delivery order was issued under a larger indefinite delivery contract awarded to Biofire Defense in September 2023, with a potential value of $18.8 million...

This is a $160,848,139.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Cangene Corporation for the development of anthrax therapeutics. The contract has an ultimate completion date of September 30, 2023 and utilizes a combination of pricing types. There is no set-aside designation for this award. The contract is for the research and development of medical countermeasures against anthrax, a critical component of the...

This is a definitive contract awarded by the Department of the Army's Joint PEO Chemical and Biological Defense, a defense agency, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $366,290,602.35 cost-plus-fixed-fee contract is for the Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) Capability, with a period of performance through October 31, 2023. As a prime contractor, Resilience has provided a range of goods and services related...

This is a $99,941,719.80 definitive, firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense, on March 16, 2017. The contract has an ultimate completion date of March 15, 2019 and is not set aside. Emergent Biodefense is a for-profit manufacturer of medical countermeasures and biopharmaceuticals, specializing in vaccines and therapeutics for public health...

This is a definitive contract awarded by the Naval Supply Systems Command (NAVSUP) to Battelle Memorial Institute, a nonprofit research and development organization, for $1,911,566.43. The contract is to provide support to the Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense (JRO-CBRND), with a completion date of October 5, 2015. The contract has no set-aside designation. The contract includes a subcontract to General Dynamics Information Technology, Inc....

This is a $30,559,760.00 cost-plus-fixed-fee delivery order awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The contract is for the development of the MAPP biopharmaceutical Viral Hemorrhagic Fever (VHF) Medical Countermeasure (MCM) platform. This work is being performed under the Centers for Innovation in...

This is a $53,950,698.73 definitive contract awarded by the Joint PEO Chemical and Biological Defense to Battelle Memorial Institute, a nonprofit research and development organization, for engineering and manufacturing development of the Common Analytical Laboratory Systems (CALS) program. The contract has a period of performance through September 30, 2020 and utilizes a cost plus incentive fee pricing type. No set-aside designation is specified. Major subcontractors include Logistic Services...